Aurigene’s Digital Edge Suite

Empowering smarter, faster, efficient and seamlessly integrated drug discovery, development, and manufacturing capabilities

At the core of Aurigene’s CRDMO transformation lies the Digital Edge Suite—a curated collection of next-generation digital platforms. With integrated tools enhancing collaboration, data transparency, and operational precision, the Digital Edge Suit supports and streamlines every stage of the drug development journey— from early discovery through development, manufacturing, and eventual market launch.

This digital ecosystem brings together cross-functional teams, harmonizes complex data streams, and enables real-time decision-making across scientific, regulatory, and operational domains. Thus, the Digital Edge Suite dissolves the traditional silos and enables seamless information flow, accelerating projects without compromising on compliance or quality.

We designed each platform within the suite keeping in mind the scalability and adaptability aspects and ensured that as project needs evolve, the digital infrastructure will be able to scale effortlessly. With supports from enhanced data integrity, AI-supported insights, and intuitive interfaces, teams can focus more on science and strategy while reducing manual effort and risk.

Ultimately, the Digital Edge Suite is beyond a technological upgrade; it is a strategic enabler that brings efficiency, accuracy, and agility to the forefront of the CRDMO process, helping clients accelerate innovation and bring therapies to patients with greater confidence and speed.

Aurigene Digital Nexus

This schematic offers a clear view of Digital Edge Suite mapped across CRO, CDMO, and integrated CRDMO services.

Digital Edge Suite Components

Aurigene.AI AI-Assisted Drug Discovery
ADME Bot Automation in In Vitro DMPK
Cell Line Analysis Automation Enhancing In Vitro Biology Throughput
In Vivo Bot Streamlining PK Data Processing
NMR Reporting Automation Speeding Up MedChem Analytics

Electronic Lab Notebook (ELN) Regulatory-Ready Scientific Recording
R&D Datalake Unified Experimental Intelligence
M&Q Datalake Manufacturing Data for Real-Time Action
Galaxy-PlanX Integrated Project Management
DocHub Smart, Centralized Documentation

Digital QMS Agile Quality Management
Digital LMS Workforce Learning and Compliance
Digital Technology Transfer Scaling Process with Precision
Cybersecurity Protecting Data, Trust, and Continuity

Connect with our scientific experts for your drug discovery, development, and manufacturing needs

We understand that clear communication is essential to successful collaborations, and that's why we have a dedicated team that is always ready to help you. Whether you have questions about our services, want to discuss a potential partnership, or simply want to learn more about our company, we're here to help.

Our team of experts is dedicated to providing personalised solutions tailored to your unique needs. So, please don't hesitate to reach out to us. We look forward to hearing from you and helping you achieve your business goals.

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

I agree to receive updates from Aurigene

* I agree and accept the Privacy Policy and Terms of Use of this website.

Page name

page url

Learning Resource

AI and Drug Discovery

ADMET Predictive Models in Aurigene.AI

JANUARY 30, 2025

Studies and Research

PROTACs: Research for a life without cancer

OCTOBER 09, 2024

Studies and Research

Good practices in non-clinical toxicology assessment to accelerate IND and NDA Submissions

OCTOBER 09, 2024

Development and Manufacturing

Continuous Flow Chemistry: A Game-Changer for Pharmaceutical Production

SEPTEMBER 17, 2024

mRNA Therapeutics

mRNA Technology and the Brief History of New Vaccine

JULY 25, 2024

AI and Drug Discovery

Revolutionizing Drug Discovery with AI: A Journey into the Future of Medicine

JUNE 18, 2024

Analytical R&D

Troubleshooting and Performance Improvement for HPLC

MAY 28, 2024

Medical Chemistry

Navigating the Surge in Demand for Lipid Nano Carriers: Challenges and Future Perspectives

MAY 16, 2024

Analytical R&D

Challenges and winning strategies to develop an analytical method for Nitrosamines

MAY 15, 2024

CPHI Milan

Why meet us at CPHI Milan?

AUGUST 29, 2024

Drug Development

A Brief Introduction to Click Chemistry and Bioorthogonal Chemistry

AUGUST 23, 2023

AI and Drug Discovery

How AI can accelerate drug discovery

JULY 05, 2023

Drug Development

“Bathtub Chemistry” - Necessity and Aspects of Process Research

MAY 19, 2023

Business Continuity

The importance of business continuity planning in CRDMO industry

NOVEMBER 16, 2023

Large Molecule Discovery Services

Neoantigen Specific T cells For Cancer Immunotherapy

JUNE 28, 2022

Pharmaceutical Services

Oligonucleotide as a novel class of therapeutic modality

JULY 02, 2021

Studies and Research

The influence of formulation development and its route of administration

JANUARY 04, 2021

Pharmaceutical Services

The Importance of Carbohydrate Synthesized Drugs

JANUARY 04, 2021

Development and Manufacturing

Application and Manufacturing of High Potent Active Pharmaceutical Ingredient (HPAPI)

JANUARY 04, 2021

Studies and Research

Role of Peptide Synthesis Based Drugs

JANUARY 04, 2021

Studies and Research

The Role of DMPK Studies in Drug Discovery

JANUARY 04, 2021

Development and Manufacturing

Application of mPEGs in Drug Discovery and Development

JANUARY 04, 2021

Drug Development

Importance of Route Scouting in Chemical Development

FEBRUARY 05, 2021

Development and Manufacturing

Introduction to PROTAC

FEBRUARY 08, 2021

Development and Manufacturing

Advantages of PROTACs over traditional drugs

JUNE 30, 2022

In vivo Pharmacokinetics (PK) Studies and Services

Development and Manufacturing

Emerging Trends in Solid State Phase Peptide Synthesis

FEBRUARY 23, 2021

View All

Small Molecules Discovery Services

Enhanced AMES Test (EAT) for Nitrosamine Impurity Risk assessment

PROTAC Research

CDMO Services

AI-assisted Drug Discovery

View All

Overcoming challenges with cyclic peptides for In-vitro experiments and Bioanalysis

Case study: Tackling CYP 2C9 inhibition challenges

LC-MS/MS method for quantification of a highly polar, rarely encountered peptide

Aurigene's DMPK Expertise

Quantification (PK evaluation) of small anti-sense oligonucleotides (ASOs) in animal tissues and studying the effect of ASO modifications on tissue accumulation and activity

Anti-Infective Drug Discovery

Manufacturing an activated mPEG derivative

Familiarization, process optimization and non- GMP manufacturing & supply of 3.0 kg of HPAPI product

Solid dispersion development to enhance solubility and oral bioavailability for rodent toxicology studies

Delivering 3 g dose of emetic and poorly bioavailable compound for 90 days repeated dose toxicity studies in dog

Expediting early development through innovative precision capsule filling technology

Systematic formulation design - shorten development cost & time

Gastro Retentive Dosage Form

Developing a methodology for In situ perfusion based combined tissue distribution and toxicity evaluation study

Fixed Dose Combination Formulation

Development of quick quantification method for muscle injury recovery evaluation in thermal injury mice model

Designing a novel methodology for the development of a macrocyclic peptide molecule for both formulation development and pre-clinical studies

Advancing a target molecule from in vitro studies to clinical supply: An innovative scientific solution

Mitigating the manufacturing challenge of a New Chemical Entity comprising peptidomimetic molecule in order to achieve the desired scale-up

How the re-designed synthesis of a complex carbohydrate can reduce cycle time

Low yield challenges of a typical reaction

Product development in a challenging IP landscape

Mitigating technical challenges and cost impacts by improved process design

Route scouting for an enantiomerically enriched Isoflavone

Pharmacokinetic (PK) study of a compound following single dose intravenous and oral administration to female beagle dogs in a crossover design.

PK properties of a compound and study its effect on animal (dog) model

Technology meets sustainability - How a complex API development process goes green

View All

Immuno Oncology - Therapies and Challenges

Building successful long-term partnerships with CDMOs from early drug discovery through commercialization

Accelerating Drug Discovery Through Innovative Partnerships

Evolution in Pharma Industry and Demand for Integrated CDMO

Peptide Development and Manufacturing

View All

Development of novel paullone-based PROTACs as anticancer agents

Development and verification of RP-HPLC method for the quantitative determination of Decitabine in tablet dosage formulation

The Impact of Nano-Suspensions on Drug Delivery: Enhancing Solubility and Therapeutic Efficacy

Visible Light Mediated One Pot Synthesis of 2,5-Disubstituted 1,3,4-Oxadiazole

Strategies for Controlling Particle Size in Injectable Nanosuspensions and Emulsions: Techniques and Future Opportunities

Development of novel paullone derivatives as selective acetylcholinesterase inhibitors for the treatment of Alzheimer’s disease

New MCR for the Rapid Construction of Polysubstituted Pyridines in Aqua Media Using (Bu3Sn)2MoO4 as Green and Sustainable Catalyst

Identification of Degradants of Thermal and Oxidation Stress Studies of Empagliflozin and Linagliptin Tablets by HPLC-PDA and LC-MS Instrumental Techniques

Analytical Method Development and Verification of Dapagliflozin Related Substances Estimation in Dapagliflozin Tablets by RP-HPLC

A simple RP-HPLC method development and verification of the Dissolution of Bromelain-A Complex mixture of proteolytic enzymes, in delayed release tablets

A sensitive and a simple RP-HPLC method development and verification for the quantitative estimation of Cholecalciferol in tablets

A simple RP-HPLC method development and verification for the quantitative estimation of Sodium Butyrate in tablets

Formulation Development and Characterization of ION and PH Dual Activated Nasal IN-SITU Gel Containing Levodopa and Carbidopa for the treatment of Parkinson’s Disease

An efficient four-component protocol for synthesis of poly-substituted pyridines with SiO2 as a robust recyclable catalyst

Scaling Injectable Pharmaceuticals: Roadblocks And Strategies

Lyophilization Unveiled: Advancing Suspension Formulation with Cutting-edge Techniques and Innovations

Quinoline hybrid derivatives as effective structural motifs in the treatment of tuberculosis: Emphasis on structure-activity relationships

Analytical Method Development and Verification of Dapagliflozin related Substances Estimation in Dapagliflozin tablets by RP-HPLC

Sequential Decarboxylation, Substitution, Cyclization and Oxidation with Iodine-DMSO Catalytic System: A New Methodology for the Construction of Imidazoquinoxaline Motifs

Development of Novel Paullone-based PROTACs as CDK1 Degraders for the Treatment of Breast and lung Cancer

Mass Directed Purification: Accelerating drug discovery

Modulation of Stem Cell Factor by Forskolin Inhibits Progression of Tubule Interstitial Fibrosis in Mice

Alternate end-game strategies towards Nirmatrelvir synthesis: Defining a continuous flow process for the preparation of an anti-COVID drug

A Sensitive and a Simple RP-HPLC Method Development and Verification for the Quantitative Estimation of Cholecalciferolin Tablets

Design and Synthesis of (3′-Benzyloxy)-3-fluoro-5-(4-methylpiperazine-1-yl)-[1,1′′′′′-biphenyl]carbaldehyde and Indanone Derivatives and their Antibacterial Activity Close to Fab I Inhibitors

A versatile design and synthesis of 3’-benzyloxy)-3-flouro-5-(4-methylpiperazine-1-yl)-[1,1’-biphenyl] carbaldehyde and indanone derivatives and their anti bacterial activity close to Fab I inhibitors

A novel processes for the preparation of (S)-N-((3R,4S,5S)-1-((S)-2-((1R,2R)-3-(((1S,2R)-1-hydroxy-1-phenylpropan-2-yl)amino)-1-methoxy-2-methyl-3-oxopropyl)pyrrolidin-1-yl)-3-methoxy-5-methyl-1-oxoheptan-4-yl)-N,3-dimethyl-2-((S)-3-methyl-2-(methylamino)

Development of a Stable Intravenous Injectable Formulation of Highly Hydrolytic Molecule in a Co-Crystal With a Highly Hydrophobic (A1) & Highly Hydrophilic (A2) Drug Substance

Formulation Development of Programmable Drug Delivery of Multi-Unit Systems for the Delayed and Extended Release of Fixed Dose Combination Drugs

Discovery of MAP855, an Efficacious and Selective MEK1/2 Inhibitor with an ATP-Competitive Mode of Action.

Synthesis of Anti-covid Drug Nirmatrelvir Using Flow Chemistry

Simple and efficient synthesis of imidazoquinoxalines and spiroquinoxalinones via pictect-spengler reaction using Wang resin, Synthetic Communications

Polycyclic Aromatic Compounds: A Simple and Efficient [(n-Bu3Sn)2MO4]n Catalyzed Synthesis of Quinazolinones and Dihydroquinazolinones

Wang-OSO 3 H catalyzed green synthesis of bioactive isoindolo[2,1- a ]quinazoline-5,11–dione derivatives: An unexpected observation

Urea as an Ammonia Surrogate in the Hantzsch’s Synthesis of Polyhydroquinolines / 1,4-dihydropyridines under Green Reaction Conditions

A Complete Recapitulation of a Drug Delivery Based on Osmotic Pressure: An Osmotic Drug Delivery System

Synacinn TM : Bacterial reverse mutation test data in five histidine-requiring strains of Salmonella Typhimurium

Ultrasound assisted rapid synthesis of mefenamic acid based indole derivatives under ligand free Cu-catalysis: Their pharmacological evaluation

Base mediated spirocyclization of quinazoline: one-step synthesis of spiro-isoindolinone dihydroquinazolinones

Dhananjaya, G., AV Dhanunjaya Rao, Kazi Amirul Hossain, Venkateswara Rao Anna, and Manojit Pal. "In silico studies and β-cyclodextrin mediated neutral synthesis of 4-oxo-4, 5, 6, 7-tetrahydroindoles of potential biological interest." Tetrahedron Letters 6

Formal synthesis of Cladospolide C & epi-Cladospolide C using R- (þ)-g-valerolactone as a chiral synthon

Lipoplex-based therapeutics for effective oligonucleotide delivery: a compendious review

Amberlite-15 promoted an unprecedented aza Michael rearrangement for one pot synthesis of dihydroquinazolinone compounds

A convergent approach towards the synthesis of the 2-alkylsubstituted tetrahydroquinoline alkaloid ()-cuspareine

A diastereoselective synthesis of boceprevir's gem-dimethyl bicyclic [3.1.0] proline intermediate from an insecticide ingredient ciscypermethric acid

Synthesis of (+)-Patulolide C Using R-(+)-g-Valerolactone as a Chiral Synthon.

Novel highly selective peroxisome proliferator-activated receptor d (PPARd) modulators with pharmacokinetic properties suitable for once-daily oral dosing

A cascade reaction for the new and direct synthesis of indolofuroquinoxalines

Synthesis of 2-hydroxy-3-alkyl-2-phenyl-2,3- dihydroquinazolin-4(1H)-one via molybdenum hexacarbonyl mediated CO gas- and ligand free carbonylative reactions

An efficient and convenient protocol for the synthesis of tetracyclic isoindolo[1,2-a]quinazoline derivatives

A concise stereoselective synthesis of (+)-1-deoxy-6-epicastanospermine

A Simple Approach for the Synthesis of Fused Quinazoline-Based Tetracyclic Compounds via a Multicomponent Reaction Strategy

Stereoselective synthesis of (R)-() and (S)-(+)-phoracantholide I from (R)-(+)-c-valerolactone

Concise and highly stereoselective syntheses of D-fagomine and 2-epi-fagomine

A new strategy for accessing (S)-1-(furan-2-yl)pent-4-en-1-ol: a key precursor of Ipomoeassin family of compounds and C1–C15 domain of halichondrins

FeF3-catalyzed MCR in PEG-400: ultrasound assisted synthesis of N-substituted 2- aminopyridines

Development of a Chemoenzymatic Process for Dehydroepiandrosterone Acetate Synthesis

Discovery of (R,E)‑N‑(7-Chloro-1-(1-[4-(dimethylamino)but-2- enoyl]azepan-3-yl)‑1H‑benzo[d]imidazol-2-yl)-2-methylisonicotinamide (EGF816), a Novel, Potent, and WT Sparing Covalent Inhibitor of Oncogenic (L858R, ex19del) and Resistant (T790M) EGFR Muta...

A metal catalyst-free and one-pot synthesis of (3,4- dihydro-2H-benzo[b][1,4]oxazin-2-yl)methanol derivatives in water

An efficient one pot synthesis of 2-amino quinazolin-4(3H)-one derivative via MCR strategy

Sulfonic acid functionalized Wang resin (Wang-OSO3H) as polymeric acidic catalyst for the eco-friendly synthesis of 2,3-dihydroquinazolin-4(1H)-ones

A short diastereoselective synthesis of cis-(2S,4S) and cis-(2R,4R)-4- hydroxyprolines

A greener approach towards double heteroarylation of N, O and S nucleophiles: synthesis of bioactive polynuclear fused Nheteroarenes

Diastereoselective total synthesis of piperidine alkaloids: (2R,5R)- 5-hydroxyhomopipecolic acid and (2R,5R,8R)-5-hydroxysedamine

Diversity oriented concise asymmetric synthesis of azasugars: a facile access to L-2,3-trans-3,4-cis-dihydroxyproline and (3S,5S)-3,4,5-trihydroxypiperidine

Discovery of O-(3-carbamimidoylphenyl)-L-serine amides as matriptase inhibitors using a fragment-linking approach

Discovery of 1H-pyrazolo[3,4-b]pyridines as potent dual orexin receptor antagonists (DORAs)

A simple access to N-(un)substituted isoquinolin1(2H)-ones: unusual formation of regioisomeric isoquinolin-1(4H)-ones

Reactions of salicylaldehydes with activated terminal alkynes in aqueous media: synthesis of 3- substituted 4-hydroxy chromenes as potential cytotoxic agents

An oxidative amidation and heterocyclization approach for the synthesis of β-carbolines and dihydroeudistomin Y

Synthesis of tetrahedral diarylheptanoid ent-diospongin A and epimer-diospongin B by employing Julia–Kocienski olefination

Applications of Gage Reproducibility & Repeatability (GRR): Understanding and Quantifying the Effect of Variations from Different Sources on a Robust Process Development

Effect of Aqueous Polyethylene Glycol on 1,3-Dipolar Cycloaddition of Benzoylnitromethane/Ethyl 2-Nitroacetate with Dipolarophiles: Green Synthesis of Isoxazoles and Isoxazolines

3‑Alkoxy-pyrrolo[1,2‑b]pyrazolines as Selective Androgen Receptor Modulators with Ideal Physicochemical Properties for Transdermal Administration

Optimization of Spray Drying Process using Central Composite Design (CCD)

Formulation and Evaluation of Controlled Porosity Osmotic Drug Delivery System of Metoprolol Succinate

Design and Synthesis of Novel 2- Substituted Benzothiazole Compounds as PTP1B Inhibitors

Synthesis of enantiomerically pure N-(2,3-dihydroxypropyl)arylamides via oxidative esterification

Cu-catalyzed coupling-cyclization in PEG 400 under ultrasound: a highly selective and greener approach towards isocoumarins

Diastereoselective total synthesis of 3,6-disubstituted piperidine alkaloids, (3R,6S)-epi-pseudoconhydrine and (3R,6R)-pseudoconhydrine

Identification of a Novel Series of Orexin Receptor Antagonists with a Distinct Effect on Sleep Architecture for the Treatment of Insomnia

Design and synthesis of 2-substituted benzoxazoles as novel PTP1B inhibitors

Construction of a six-membered fused N-heterocyclic ring via a new 3-component reaction: synthesis of (pyrazolo)pyrimidines/pyridinesw

Construction of a quinoline ring via a 3-component reaction in water: crystal structure analysis and H-bonding patterns of a 2-aryl quinoline

An Efficient and Practical Synthesis of Aryl and Hetaryl a-Keto Esters

Synthesis of Isoquinoline Alkaloids via Oxidative Amidation–Bischler– Napieralski Reaction

Iodine catalyzed four-component reaction: a straightforward one-pot synthesis of functionalized pyrroles under metal-free conditions

N-heterocyclic carbene-mediated hydroacylation–Sonogashira/Heck/Suzuki coupling in a single pot: A new cascade reaction

Synthesis of novel 5-alkyl/aryl/heteroaryl substituted diethyl 3,4-dihydro-2H-pyrrole-4,4-dicarboxylates by aziridine ring expansion of 2-[(aziridin-1-yl)-1-alkyl/ aryl/heteroaryl-methylene]malonic acid diethyl esters

Yb(OTf)3 catalyzed new cascade reaction: a facile assembly of fused quinazolinones

Transition metal mediated construction of pyrrole ring on 2,3-dihydroquinolin-4(1H)-one: synthesis and pharmacological evaluation of novel tricyclic heteroarenes

A Concise and Cascade Synthesis of Batracylin and Substituted Isoindolo- [1,2-b]quinazolin-12(10H)-ones

A Concise and Convergent Synthesis of Luotonin B and E

Design and Development of a Fixed Dose Combination (FDC) of Delayed-Extended Release Niacin and a Flushing Modulator For Sequential Release

Optimization of formulation and process variable of nanosuspension: An industrial perspective

A highly effective synthesis of 2-alkynyl-7-azaindoles: Pd/C-mediated alkynylation of heteroaryl halides in water

Revisiting the reaction of b-chloroacroleins with 2-aminophenol: a new observation

Tandem versus single C–C bond forming reaction under palladium–copper catalysis: regioselective synthesis of a-pyrones fused with thiophene

Palladium-mediated synthesis of 5-substituted 4-alkynylthieno[2,3-c]pyran-7-onesq

View All

You are about to leave Aurigene Pharmaceutical Services and affiliates website. Aurigene Pharmaceutical Services assumes no responsibility for the information presented on the external website or any further links from such sites. These links are presented to you only as a convenience, and the inclusion of any link does not imply endorsement by Aurigene Pharmaceutical Services.

If you wish to continue to this external website, click Proceed.

Proceed Back

Aurigene’s Digital Edge Suite

Aurigene Digital Nexus

Digital Edge Suite Components

Connect with our scientific experts for your drug discovery, development, and manufacturing needs

section

rightCaptcha

Learning Resource

ADMET Predictive Models in Aurigene.AI

PROTACs: Research for a life without cancer

Good practices in non-clinical toxicology assessment to accelerate IND and NDA Submissions

Continuous Flow Chemistry: A Game-Changer for Pharmaceutical Production

mRNA Technology and the Brief History of New Vaccine

Revolutionizing Drug Discovery with AI: A Journey into the Future of Medicine

Troubleshooting and Performance Improvement for HPLC

Navigating the Surge in Demand for Lipid Nano Carriers: Challenges and Future Perspectives

Challenges and winning strategies to develop an analytical method for Nitrosamines

Why meet us at CPHI Milan?

A Brief Introduction to Click Chemistry and Bioorthogonal Chemistry

How AI can accelerate drug discovery

“Bathtub Chemistry” - Necessity and Aspects of Process Research

The importance of business continuity planning in CRDMO industry

Neoantigen Specific T cells For Cancer Immunotherapy

Oligonucleotide as a novel class of therapeutic modality

The influence of formulation development and its route of administration

The Importance of Carbohydrate Synthesized Drugs

Application and Manufacturing of High Potent Active Pharmaceutical Ingredient (HPAPI)

Role of Peptide Synthesis Based Drugs

The Role of DMPK Studies in Drug Discovery

Application of mPEGs in Drug Discovery and Development

Importance of Route Scouting in Chemical Development

Introduction to PROTAC

Advantages of PROTACs over traditional drugs

Emerging Trends in Solid State Phase Peptide Synthesis

Small Molecules Discovery Services

Enhanced AMES Test (EAT) for Nitrosamine Impurity Risk assessment

PROTAC Research

CDMO Services

AI-assisted Drug Discovery

Overcoming challenges with cyclic peptides for In-vitro experiments and Bioanalysis

Case study: Tackling CYP 2C9 inhibition challenges

LC-MS/MS method for quantification of a highly polar, rarely encountered peptide

Aurigene's DMPK Expertise

Quantification (PK evaluation) of small anti-sense oligonucleotides (ASOs) in animal tissues and studying the effect of ASO modifications on tissue accumulation and activity

Anti-Infective Drug Discovery

Manufacturing an activated mPEG derivative

Familiarization, process optimization and non- GMP manufacturing & supply of 3.0 kg of HPAPI product

Solid dispersion development to enhance solubility and oral bioavailability for rodent toxicology studies

Delivering 3 g dose of emetic and poorly bioavailable compound for 90 days repeated dose toxicity studies in dog

Expediting early development through innovative precision capsule filling technology

Systematic formulation design - shorten development cost & time

Gastro Retentive Dosage Form

Developing a methodology for In situ perfusion based combined tissue distribution and toxicity evaluation study

Fixed Dose Combination Formulation

Development of quick quantification method for muscle injury recovery evaluation in thermal injury mice model

Designing a novel methodology for the development of a macrocyclic peptide molecule for both formulation development and pre-clinical studies

Advancing a target molecule from in vitro studies to clinical supply: An innovative scientific solution

Mitigating the manufacturing challenge of a New Chemical Entity comprising peptidomimetic molecule in order to achieve the desired scale-up

How the re-designed synthesis of a complex carbohydrate can reduce cycle time

Low yield challenges of a typical reaction

Product development in a challenging IP landscape

Mitigating technical challenges and cost impacts by improved process design

Route scouting for an enantiomerically enriched Isoflavone

PK properties of a compound and study its effect on animal (dog) model

Technology meets sustainability - How a complex API development process goes green

Immuno Oncology - Therapies and Challenges

Building successful long-term partnerships with CDMOs from early drug discovery through commercialization

Accelerating Drug Discovery Through Innovative Partnerships

Evolution in Pharma Industry and Demand for Integrated CDMO

Peptide Development and Manufacturing

Development of novel paullone-based PROTACs as anticancer agents

Development and verification of RP-HPLC method for the quantitative determination of Decitabine in tablet dosage formulation

The Impact of Nano-Suspensions on Drug Delivery: Enhancing Solubility and Therapeutic Efficacy

Visible Light Mediated One Pot Synthesis of 2,5-Disubstituted 1,3,4-Oxadiazole

Strategies for Controlling Particle Size in Injectable Nanosuspensions and Emulsions: Techniques and Future Opportunities

Development of novel paullone derivatives as selective acetylcholinesterase inhibitors for the treatment of Alzheimer’s disease

New MCR for the Rapid Construction of Polysubstituted Pyridines in Aqua Media Using (Bu3Sn)2MoO4 as Green and Sustainable Catalyst

Identification of Degradants of Thermal and Oxidation Stress Studies of Empagliflozin and Linagliptin Tablets by HPLC-PDA and LC-MS Instrumental Techniques

Analytical Method Development and Verification of Dapagliflozin Related Substances Estimation in Dapagliflozin Tablets by RP-HPLC

A simple RP-HPLC method development and verification of the Dissolution of Bromelain-A Complex mixture of proteolytic enzymes, in delayed release tablets

A sensitive and a simple RP-HPLC method development and verification for the quantitative estimation of Cholecalciferol in tablets